We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IVZ Among Top-Performing S&P 500 Asset Managers in 2025: Is It a Buy?
Read MoreHide Full Article
Key Takeaways
IVZ rallied 53.5% in 2025, outperforming peers like Franklin Resources and T. Rowe Price.
IVZ's AUM saw an 8.5% CAGR over five years, aided by passive demand.
Muted revenue trends and $14.2B in intangible assets affect optimism, leading investors to wait.
The performance of the Invesco (IVZ - Free Report) stock has been impressive in 2025. With a 53.5% rally, the company has become one of the top-performing S&P 500 asset managers this year, outpacing the S&P 500 index’s growth of 20.1% and the industry’s 10.9% decline.
If we look at the price performance of two of IVZ’s close peers, T. Rowe Price (TROW - Free Report) and Franklin Resources, Inc. (BEN - Free Report) , it appears that Invesco has fared better than them. In 2025, the BEN stock has gained 20.2%, whereas TROW shares have lost 7.6%.
2025 Price Performance
Image Source: Zacks Investment Research
Now, the question arises whether investors should buy the IVZ stock now, given its impressive price performance. Before taking any investment decision, it is advised to look at the fundamentals and growth prospects of the company to clearly understand its risks and rewards.
Invesco’s Positives to Note
Robust AUM Balance: IVZ has been witnessing a consistent improvement in its assets under management (AUM) balance. Though the company’s total AUM declined in 2022, the metric witnessed a compound annual growth rate (CAGR) of 8.5% in the last five years ended 2024, with the uptrend continuing in the first nine months of 2025.
The 2019 acquisition of OppenheimerFunds resulted in a substantial rise in the company's AUM, making it one of the leading global asset managers. Also, Invesco has been capitalizing on the growing demand for passive products, which constituted 47.4% of total AUM as of Sept. 30, 2025.
In April 2025, IVZ collaborated with MassMutual’s subsidiary, Barings, to boost its private credit offerings. Also, the company has been seeking shareholder approval to convert the Invesco QQQ Trust from a unit investment trust (UIT) to an open-end ETF, enabling it to earn revenues and profits instead of just recouping marketing costs.
QQQ has operated under a legacy UIT structure since its 1999 launch, which helped establish the fund but now restricts reinvesting dividends, securities lending and other efficiencies. As ETFs have evolved, UITs have become costlier and less flexible. The reclassification aims to align QQQ with today’s open-end ETF model to unlock operational efficiencies and reduce the expense ratio. The move aligns with IVZ’s efforts to grow its AUM balance.
Improving Operating Efficiency: Invesco has been undertaking initiatives to improve operating efficiency. The company exceeded its target of realizing net cost synergies from the OppenheimerFunds acquisition and achieved $200 million in annualized net savings well ahead of schedule.
In August 2025, it announced a deal to sell Intelliflo, which it had acquired in 2018, to Carlyle Group to boost efficiency. While adjusted operating expenses increased in 2023 and in the first nine months of 2025, the metric declined 2.2% in 2024.
Management’s continuous efforts to manage its expenses prudently will likely lead to higher operating leverage going forward.
Solid Global Presence: Apart from a strong presence in the United States, Invesco maintains a solid foothold in Europe, Canada and the Asia Pacific. As of Sept. 30, 2025, the company’s client AUM outside the United States constituted 31% of the total AUM. The acquisition of Europe-based Source, a leading, independent specialist provider of ETFs, will drive Invesco’s global presence.
Also, the sale of the majority stake in the India business to establish a joint venture will strengthen IVZ’s Asia presence, while allowing capital allocation to more profitable projects.
These and other diversification efforts will likely help the company generate further momentum from its business outside the United States.
Strong Balance Sheet Position: As of Sept. 30, 2025, Invesco had total debt, including debt of consolidated investment products (CIP), of $9.94 billion, significantly higher than cash and cash equivalents of $973.1 million.
Additionally, the company maintains a stable outlook and investment-grade long-term senior debt ratings of A3, BBB+ and A from Moody’s Investors Service, S&P Ratings and Fitch Ratings, respectively. This renders the company favorable access to the debt market.
This also enables Invesco to pursue efficient capital distributions. In April 2025, the company announced a 2.4% hike in its quarterly dividend to 21 cents per share. The company has been consistently raising its quarterly dividends. It hiked dividends six times in the last five years, with a dividend payout ratio of 44%.
Similarly, both T. Rowe Price and Franklin Resources have increased their dividends five times over the past five years.
Invesco’s Near-Term Headwinds
Muted Top Line: Invesco's top-line growth has been weak. Though total operating revenues increased in 2024 and the first nine months of 2025, the metric has been recording a downtrend since the second half of 2020.
Despite having a robust institutional pipeline, diverse product offerings, alternative investment strategies and solid retail channels, revenues are likely to be under pressure in the near term due to a challenging operating backdrop.
Significant Intangible Assets: As of Sept. 30, 2025, Invesco’s goodwill and net intangible assets remained considerably high, totaling $14.2 billion (49.9% of total assets).
Several factors may initiate the impairment of the book value of such assets, due to which their value may have to be written down. This is expected to negatively impact the company’s financials. In 2023, amortization and impairment of intangible assets-related charges significantly hampered the company’s financials, resulting in a net loss.
Analyzing IVZ’s Earnings Estimates & Valuation
Over the past 60 days, the Zacks Consensus Estimate for IVZ’s 2025 and 2026 earnings has been revised higher, reflecting that analysts are optimistic regarding the company’s earnings growth potential. The earnings estimate of $1.94 per share for 2025 indicates year-over-year growth of 13.5%. The 2026 estimate of $2.60 indicates growth of 34.2%.
Earnings Estimate Revision
Image Source: Zacks Investment Research
From a valuation perspective, the IVZ stock is currently trading at a forward 12-month price/earnings (P/E) ratio of 10.31X. This is below the industry average of 14.91X over the past five years, reflecting that the IVZ stock is relatively less expensive than its peers.
P/E (F12M)
Image Source: Zacks Investment Research
Final Thoughts on Invesco Stock
The QQQ reclassification, a solid global presence and a strong balance sheet are expected to keep supporting Invesco’s financials. Improving operating efficiency will further aid profitability. This is reflected in the bullish analyst sentiments. An attractive valuation adds another layer of optimism.
However, a subdued top line amid a tough operating backdrop and the company’s significant exposure to intangible assets remain concerning.
Thus, investors should not rush to buy the IVZ stock now. Investors should assess how Invesco addresses its issues before they decide to invest in it. Nevertheless, those who already own the stock should continue holding onto it for long-term gains.
Image: Shutterstock
IVZ Among Top-Performing S&P 500 Asset Managers in 2025: Is It a Buy?
Key Takeaways
The performance of the Invesco (IVZ - Free Report) stock has been impressive in 2025. With a 53.5% rally, the company has become one of the top-performing S&P 500 asset managers this year, outpacing the S&P 500 index’s growth of 20.1% and the industry’s 10.9% decline.
If we look at the price performance of two of IVZ’s close peers, T. Rowe Price (TROW - Free Report) and Franklin Resources, Inc. (BEN - Free Report) , it appears that Invesco has fared better than them. In 2025, the BEN stock has gained 20.2%, whereas TROW shares have lost 7.6%.
2025 Price Performance
Image Source: Zacks Investment Research
Now, the question arises whether investors should buy the IVZ stock now, given its impressive price performance. Before taking any investment decision, it is advised to look at the fundamentals and growth prospects of the company to clearly understand its risks and rewards.
Invesco’s Positives to Note
Robust AUM Balance: IVZ has been witnessing a consistent improvement in its assets under management (AUM) balance. Though the company’s total AUM declined in 2022, the metric witnessed a compound annual growth rate (CAGR) of 8.5% in the last five years ended 2024, with the uptrend continuing in the first nine months of 2025.
The 2019 acquisition of OppenheimerFunds resulted in a substantial rise in the company's AUM, making it one of the leading global asset managers. Also, Invesco has been capitalizing on the growing demand for passive products, which constituted 47.4% of total AUM as of Sept. 30, 2025.
In April 2025, IVZ collaborated with MassMutual’s subsidiary, Barings, to boost its private credit offerings. Also, the company has been seeking shareholder approval to convert the Invesco QQQ Trust from a unit investment trust (UIT) to an open-end ETF, enabling it to earn revenues and profits instead of just recouping marketing costs.
QQQ has operated under a legacy UIT structure since its 1999 launch, which helped establish the fund but now restricts reinvesting dividends, securities lending and other efficiencies. As ETFs have evolved, UITs have become costlier and less flexible. The reclassification aims to align QQQ with today’s open-end ETF model to unlock operational efficiencies and reduce the expense ratio. The move aligns with IVZ’s efforts to grow its AUM balance.
Improving Operating Efficiency: Invesco has been undertaking initiatives to improve operating efficiency. The company exceeded its target of realizing net cost synergies from the OppenheimerFunds acquisition and achieved $200 million in annualized net savings well ahead of schedule.
In August 2025, it announced a deal to sell Intelliflo, which it had acquired in 2018, to Carlyle Group to boost efficiency. While adjusted operating expenses increased in 2023 and in the first nine months of 2025, the metric declined 2.2% in 2024.
Management’s continuous efforts to manage its expenses prudently will likely lead to higher operating leverage going forward.
Solid Global Presence: Apart from a strong presence in the United States, Invesco maintains a solid foothold in Europe, Canada and the Asia Pacific. As of Sept. 30, 2025, the company’s client AUM outside the United States constituted 31% of the total AUM. The acquisition of Europe-based Source, a leading, independent specialist provider of ETFs, will drive Invesco’s global presence.
Also, the sale of the majority stake in the India business to establish a joint venture will strengthen IVZ’s Asia presence, while allowing capital allocation to more profitable projects.
These and other diversification efforts will likely help the company generate further momentum from its business outside the United States.
Strong Balance Sheet Position: As of Sept. 30, 2025, Invesco had total debt, including debt of consolidated investment products (CIP), of $9.94 billion, significantly higher than cash and cash equivalents of $973.1 million.
Additionally, the company maintains a stable outlook and investment-grade long-term senior debt ratings of A3, BBB+ and A from Moody’s Investors Service, S&P Ratings and Fitch Ratings, respectively. This renders the company favorable access to the debt market.
This also enables Invesco to pursue efficient capital distributions. In April 2025, the company announced a 2.4% hike in its quarterly dividend to 21 cents per share. The company has been consistently raising its quarterly dividends. It hiked dividends six times in the last five years, with a dividend payout ratio of 44%.
Similarly, both T. Rowe Price and Franklin Resources have increased their dividends five times over the past five years.
Invesco’s Near-Term Headwinds
Muted Top Line: Invesco's top-line growth has been weak. Though total operating revenues increased in 2024 and the first nine months of 2025, the metric has been recording a downtrend since the second half of 2020.
Despite having a robust institutional pipeline, diverse product offerings, alternative investment strategies and solid retail channels, revenues are likely to be under pressure in the near term due to a challenging operating backdrop.
Significant Intangible Assets: As of Sept. 30, 2025, Invesco’s goodwill and net intangible assets remained considerably high, totaling $14.2 billion (49.9% of total assets).
Several factors may initiate the impairment of the book value of such assets, due to which their value may have to be written down. This is expected to negatively impact the company’s financials. In 2023, amortization and impairment of intangible assets-related charges significantly hampered the company’s financials, resulting in a net loss.
Analyzing IVZ’s Earnings Estimates & Valuation
Over the past 60 days, the Zacks Consensus Estimate for IVZ’s 2025 and 2026 earnings has been revised higher, reflecting that analysts are optimistic regarding the company’s earnings growth potential. The earnings estimate of $1.94 per share for 2025 indicates year-over-year growth of 13.5%. The 2026 estimate of $2.60 indicates growth of 34.2%.
Earnings Estimate Revision
Image Source: Zacks Investment Research
From a valuation perspective, the IVZ stock is currently trading at a forward 12-month price/earnings (P/E) ratio of 10.31X. This is below the industry average of 14.91X over the past five years, reflecting that the IVZ stock is relatively less expensive than its peers.
P/E (F12M)
Image Source: Zacks Investment Research
Final Thoughts on Invesco Stock
The QQQ reclassification, a solid global presence and a strong balance sheet are expected to keep supporting Invesco’s financials. Improving operating efficiency will further aid profitability. This is reflected in the bullish analyst sentiments. An attractive valuation adds another layer of optimism.
However, a subdued top line amid a tough operating backdrop and the company’s significant exposure to intangible assets remain concerning.
Thus, investors should not rush to buy the IVZ stock now. Investors should assess how Invesco addresses its issues before they decide to invest in it. Nevertheless, those who already own the stock should continue holding onto it for long-term gains.
Currently, IVZ carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.